PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32934775-3	2020	We demonstrate that the administration of BAY 11-7082, either before or after acidic bile, eliminates NF-kappaB activation, prevents overexpression of Bcl2, Rela, Stat3, Egfr, Tnf, Wnt5a, and deregulations of miR-192, miR-504, linked to bile reflux-related hypopharyngeal cancer.	3-(4-methylphenylsulfonyl)-2-propenenitrile	42-53	signal transducer and activator of transcription 3	Mus musculus	163-168	
28096316-11	2017	BAY 11-7082 reduced pNF-kappaB, NLRP3, tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-6 and IL-1beta expression, blunted the phosphorylation of signal transducer and activators of transcription 3 (STAT3) and decreased IL-23 levels.	3-(4-methylphenylsulfonyl)-2-propenenitrile	0-11	signal transducer and activator of transcription 3	Mus musculus	156-207	
28096316-11	2017	BAY 11-7082 reduced pNF-kappaB, NLRP3, tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-6 and IL-1beta expression, blunted the phosphorylation of signal transducer and activators of transcription 3 (STAT3) and decreased IL-23 levels.	3-(4-methylphenylsulfonyl)-2-propenenitrile	0-11	signal transducer and activator of transcription 3	Mus musculus	209-214	
29529473-8	2018	BAY 11-7082 eliminates NF-kappaB activation in regenerating basal cells of acidic bile-treated HM and prevents overexpression of molecules central to head and neck cancer, including bcl-2, STAT3, EGFR, TNF-alpha, and WNT5A.	3-(4-methylphenylsulfonyl)-2-propenenitrile	0-11	signal transducer and activator of transcription 3	Mus musculus	189-194